BANK VONTOBEL/PUT/ROCHE GS/240/0.02/20.12.24 Share Price

Warrant

WROA1V

CH1312986420

Market Closed - Swiss Exchange 08:50:00 31/05/2024 pm IST
0.355 CHF -7.79% Intraday chart for BANK VONTOBEL/PUT/ROCHE GS/240/0.02/20.12.24
1 month-29.00%
3 months-22.83%
Date Price Change
31/24/31 0.355 -7.79%
30/24/30 0.385 +1.32%
28/24/28 0.38 +2.70%
27/24/27 0.37 +2.78%
24/24/24 0.36 +4.35%

Delayed Quote Swiss Exchange

Last update May 31, 2024 at 08:50 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Vontobel Vontobel
WROA1V
ISINCH1312986420
Date issued 09/01/2024
Strike 240 CHF
Maturity 20/12/2024 (202 Days)
Parity 50 : 1
Emission price 0.28 CHF
Emission volume N/A
Settlement physical
Currency CHF

Technical Indicators

Highest since issue 0.59 CHF
Lowest since issue 0.29 CHF
Spread 0.01 CHF
Spread %2.82%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
231 CHF
Average target price
277.5 CHF
Spread / Average Target
+20.14%
Consensus
  1. Stock Market
  2. Warrants
  3. WROA1V Warrant